Healthy Skepticism Library item: 16523
Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.
Publication type: Edited Book
Rochon Ford A, Saibil D The Push to Prescribe: Women & Canadian Drug Policy Toronto: Canadian Scholars' Press Inc. 2009 Sep
http://www.merxmotion.com/motion.asp?siteid=100366&lgid=1&menuid=5376&prodid=121201&cat=9869
Abstract:
Description
In recent years, heated debate has surrounded the pharmaceutical industry and how it has gained unprecedented control over the evaluation, regulation, and promotion of its own products. As a result, drugs are produced, regulated, marketed, and used in ways that infiltrate many aspects of everyday life. The nature and extent of this infiltration, and how this has special meaning for women, are at the core of The Push to Prescribe.
This is an essential resource for a variety of courses in Health Sciences, Medicine, Nursing, Pharmacology, Public Policy, Public Health, Health Policy, Women’s Studies, Women’s Health, as well as many Social Science courses in areas like Sociology and Political Science. It will also be of interest to a general audience, health professional organizations, government health associations, and consumer and women’s groups.
Editors
Anne Rochon Ford is the Coordinator of Women and Health Protection, a national working group mandated to provide research-based policy advice on the safety of prescription medication. Over the last decade, WHP has commissioned research on a range of topics within the field of women and pharmaceuticals, resulting in the body of work represented in this book.
Diane Saibil is a freelance writer and editor.
Table of Contents
Foreword, Nancy Olivieri
Preface
Chapter 1: Introduction, The Steering Committee of Women and Health Protection
Part I: The Push to Prescribe: Who Defines What Drugs We Need and How Do They Do It?
Chapter 2: “Ask Your Doctorâ€: Women and Direct-to-Consumer Advertising, Barbara Mintzes
Chapter 3: Preventing Disease: Are Pills the Answer? Sharon Batt and Abby Lippman
Chapter 4: Who Pays the Piper? Industry Funding of Patients’ Groups, Sharon Batt
Part II: The Canadian Drug Regulatory Process
Chapter 5: Trials on Trial: Women and the Testing of Drugs, Abby Lippman
Chapter 6: Lifting the Curtain on the Drug-Approval Process, Ann Silversides
Chapter 7: Reporting Adverse Drug Reactions: What Happens in the Real World? Colleen Fuller
Chapter 8: Questioning Modernization: Legislative Change at Health Canada, Anne Rochon Ford
Chapter 9: Full Circle: Drugs, the Environment, and Our Health, Sharon Batt
Chapter 10: Finding the Way Forward, The Steering Committee of Women and Health Protection
Further Reading
Related Websites
References
Copyright Acknowledgement
Index
Features – presents an approach that combines compelling evidence with social, political, and gender-based analyses
- discusses the complexity surrounding women and pharmaceuticals and uses the best evidence to argue for changes that better reflect women’s needs in public health policy and that ensure those who are best suited to make these determinations are included in policy-making
